Evidence map›Paper›PMID 41164576›Full record

ArticleJournal of pharmacy & bioallied sciences2025

Synthesis, Structural Analysis, and Antifungal Potential of Copper Oxide Nanoparticles against

Arti Zende, Jayant Pawar, Chitra Khanwelkar, Rohan S Phatak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Arti ZendeDepartment of Biotechnology, Krishna Institute of Science and Technology, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, Maharashtra, India.
Jayant PawarDepartment of Biotechnology, Krishna Institute of Science and Technology, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, Maharashtra, India.
Chitra KhanwelkarDepartment of Pharmacology, Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, Maharashtra, India.
Rohan S PhatakDepartment of Pharmacognosy, Krishna Institute of Pharmacy, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Recurrent vaginal infections caused by Candida species, particularly drug-resistant strains, remain a major concern in women's reproductive health. Aim: This study evaluates the antifungal potential of copper oxide nanoparticles (CuO NPs), synthesized via a semi-solvothermal method, against clinically relevant vaginal Candida species- Materials and methods: Structural and optical characterization confirmed a crystalline cubic phase (XRD), a strong UV-Vi's absorption at 340 nm with a 3.4 eV band gap, and spherical nanoparticles (10-25 nm) seen via FESEM. Antifungal activity was tested using agar well diffusion and CFU assays across 15-1000 μg/mL concentrations. Result: A concentration-dependent colony forming unit (CFU) reduction was observed, with Conclusion: These findings highlight the potential of CuO NPs as a promising antifungal agent, particularly effective against resistant or non-

Indexed as

Antagonistic activitysemi-solvo thermal methodzinc oxide nanoparticles

Identifiers

PMID41164576
PMCPMC12563392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.